Spyre Therapeutics, Inc. SYRE TX — Tenant Improvements
Discontinued — last reported Q4 '16
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Spyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:TenantImprovements.
The official record: Spyre Therapeutics, Inc.’s 10-K, filed March 7, 2019, on SEC EDGAR. View the filing →
Questions, answered.
- What does TX — tenant improvements mean?
- The total capital spent on renovating and customizing leased properties within the TX region.
- How do you interpret TX — tenant improvements?
- An increase suggests significant expansion or facility upgrades, while a decrease may indicate stable infrastructure or reduced capital investment in that region.
- How does TX — tenant improvements compare across companies?
- Peers in the biotech sector typically report these as leasehold improvements under capital expenditures, with variations based on the scale of laboratory build-outs.